UBA3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.60982338570648E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.48370005170761E-09 |
Normal-vs-Stage2 |
6.769400E-04 |
Normal-vs-Stage3 |
3.35089955783019E-10 |
Normal-vs-Stage4 |
2.63860000515592E-08 |
Stage1-vs-Stage2 |
2.326800E-01 |
Stage1-vs-Stage3 |
1.041600E-01 |
Stage1-vs-Stage4 |
8.318200E-01 |
Stage2-vs-Stage3 |
4.096200E-02 |
Stage2-vs-Stage4 |
2.381600E-01 |
Stage3-vs-Stage4 |
2.446800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.68332014993666E-12 |
Normal-vs-AfricanAmerican |
1.51900000022742E-07 |
Normal-vs-Asian |
1.910160E-01 |
Caucasian-vs-AfricanAmerican |
4.993000E-01 |
Caucasian-vs-Asian |
2.369800E-01 |
AfricanAmerican-vs-Asian |
4.533600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.80930875521335E-13 |
Normal-vs-Female |
9.97280003023349E-09 |
Male-vs-Female |
1.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.0872999995667E-07 |
Normal-vs-Age(41-60Yrs) |
2.32090002771912E-09 |
Normal-vs-Age(61-80Yrs) |
7.1078032348737E-11 |
Normal-vs-Age(81-100Yrs) |
3.2494995583221E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.958800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.620000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.694800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.185800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.047700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.305500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.637300E-03 |
Normal-vs-Grade 2 |
7.31060000314088E-08 |
Normal-vs-Grade 3 |
9.6508356861591E-12 |
Normal-vs-Grade 4 |
1.75210002062443E-09 |
Grade 1-vs-Grade 2 |
2.745400E-01 |
Grade 1-vs-Grade 3 |
1.230000E-02 |
Grade 1-vs-Grade 4 |
9.396300E-02 |
Grade 2-vs-Grade 3 |
3.237800E-03 |
Grade 2-vs-Grade 4 |
7.753700E-02 |
Grade 3-vs-Grade 4 |
9.743400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.87590004535809E-09 |
Normal-vs-ccB subtype |
2.10970000358301E-08 |
ccA subtype-vs-ccB subtype |
9.822600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.88180002083749E-09 |
Normal-vs-N1 |
5.962500E-03 |
N0-vs-N1 |
8.936000E-01 |
|
|